B Kremens

Author PubWeight™ 39.19‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000. Leukemia 2009 2.78
2 Mutations in the a3 subunit of the vacuolar H(+)-ATPase cause infantile malignant osteopetrosis. Hum Mol Genet 2000 2.04
3 Pleuro-pulmonary blastoma: a case report and review of the literature. Med Pediatr Oncol 1995 2.02
4 Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90. Blood 1999 1.75
5 Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry. J Clin Oncol 1998 1.41
6 Diffuse sclerosing variant of papillary thyroid carcinoma. S-100 protein immunocytochemistry and prognosis. Virchows Arch A Pathol Anat Histopathol 1990 1.40
7 Second malignancies after ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study. Ann Oncol 2001 1.13
8 No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors. Blood 2001 1.10
9 1070 myeloablative megatherapy procedures followed by stem cell rescue for neuroblastoma: 17 years of European experience and conclusions. European Group for Blood and Marrow Transplant Registry Solid Tumour Working Party. Eur J Cancer 1997 1.07
10 Long-term results and risk profiles of patients in five consecutive trials (1979-1997) with stage 4 neuroblastoma over 1 year of age. Cancer Lett 2003 1.04
11 Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group. Klin Padiatr 1998 1.02
12 Primary mediastinal germ cell tumors in children and adolescents: results of the German cooperative protocols MAKEI 83/86, 89, and 96. J Clin Oncol 2000 1.00
13 High-dose corticosteroid therapy for bronchiolitis obliterans after bone marrow transplantation in children. Bone Marrow Transplant 2005 0.96
14 Allogeneic bone marrow transplantation for chronic myelomonocytic leukemia in childhood: a report from the European Working Group on Myelodysplastic Syndrome in Childhood. J Clin Oncol 1997 0.96
15 Osteosarcoma after allogeneic bone marrow transplantation. A report of four cases from the Cooperative Osteosarcoma Study Group (COSS). Bone Marrow Transplant 2003 0.94
16 Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective. Bone Marrow Transplant 2004 0.94
17 Favorable outcome in infants with AML after intensive first- and second-line treatment: an AML-BFM study group report. Leukemia 2011 0.92
18 Reduced intensity conditioning in unrelated donor transplantation for refractory cytopenia in childhood. Bone Marrow Transplant 2007 0.92
19 Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia. Leukemia 2005 0.89
20 Loss of blood pressure control on withdrawal of fluconazole during nifedipine therapy. Br J Clin Pharmacol 1999 0.89
21 Impaired renal function and tumor lysis syndrome in pediatric patients with non-Hodgkin's lymphoma and B-ALL. Observations from the BFM-trials. Klin Padiatr 1998 0.88
22 TEL-AML1 fusion transcript in relapsed childhood acute lymphoblastic leukemia. The Berlin-Frankfurt-Münster Study Group. Blood 1998 0.87
23 Key treatment questions in childhood acute lymphoblastic leukemia: results in 5 consecutive trials performed by the ALL-BFM study group from 1981 to 2000. Klin Padiatr 2013 0.86
24 Immunological detection of neuroblastoma cells in bone marrow harvested for autologous transplantation. Br J Cancer 1989 0.86
25 Allo-SCT using BU, CY and melphalan for children with AML in second CR. Bone Marrow Transplant 2012 0.85
26 Haematopoietic stem cell transplantation for amegakaryocytic thrombocytopenia. Br J Haematol 2000 0.83
27 Allogeneic stem cell transplantation for pediatric and adolescent patients with CML: results from the prospective trial CML-paed I. Klin Padiatr 2009 0.82
28 The role of chemotherapy in the treatment of children with neuroblastoma stage IV: the GPO (German Pediatric Oncology Society) experience. Klin Padiatr 1990 0.82
29 Second German consensus on immunogenetic donor search for allotransplantation of hematopoietic stem cells. Ann Hematol 2001 0.79
30 Does megatherapy contribute to survival in metastatic neuroblastoma? A retrospective analysis. German Cooperative Neuroblastoma Study Group. Klin Padiatr 1997 0.78
31 S-L 11.14: a monoclonal antibody recognizing neuroectodermal tumors with possible value for bone marrow purging before autograft. Bone Marrow Transplant 1988 0.78
32 Phase II studies of combinations of drugs with high dose carboplatin in neuroblastoma (800 mg/m2 to 1 g 250/m2): a report from the LMCE group. Prog Clin Biol Res 1988 0.78
33 Definition of response and remission in children over one year of age with advanced neuroblastoma: proposition for a scoring system. Pediatr Hematol Oncol 1987 0.77
34 Serial measurements of neuropeptide Y in plasma for monitoring neuroblastoma in children. J Pediatr 1993 0.77
35 Role of allogeneic bone marrow transplantation for the treatment of myelodysplastic syndromes in childhood. The European Working Group on Childhood Myelodysplastic Syndrome (EWOG-MDS) and the Austria-Germany-Italy (AGI) Bone Marrow Transplantation Registry. Bone Marrow Transplant 1996 0.77
36 Immunoglobulin and T-cell receptor gene rearrangements as PCR-based targets are stable markers for monitoring minimal residual disease in acute lymphoblastic leukemia after stem cell transplantation. Leukemia 2009 0.76
37 Collection of peripheral progenitor cells in paediatric patients with a new programme for the collection of mononuclear cells. J Clin Apher 2003 0.76
38 Transplantation of filgrastim-mobilized peripheral blood stem cells from HLA-identical sibling or alternative family donors in patients with hematologic malignancies: a prospective comparison on clinical outcome, immune reconstitution, and hematopoietic chimerism. Blood 1997 0.76
39 Collision tumor in children: a review of the literature and presentation of a rare case of mesoblastic nephroma and neuroblastoma in an infant. J Pediatr Surg 2001 0.75
40 Differential diagnosis of cholestasis following allogeneic hematopoietic stem cell transplantation in children: the contribution of serum bile acid levels in relation to other liver function tests. Pediatr Hematol Oncol 2004 0.75
41 High dose consolidation with autologous stem cell rescue (ASCR) for nephroblastoma initially treated according to the SIOP 9/GPOH trial and study. Klin Padiatr 1996 0.75
42 [Experiences with a modified implantation technique of Port-A-Cath systems as continuous venous access in infants and children]. Med Klin (Munich) 1991 0.75
43 Recurrent disseminated retinoblastoma in a 7-year-old girl treated successfully by high-dose chemotherapy and CD34-selected autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 2001 0.75
44 [Indications for bone marrow transplantation in sickle cell anemia]. Klin Padiatr 1994 0.75
45 [Metastatic neuroblastoma with secondary hypersecretion of vasoactive intestinal peptide]. Pediatrie 1988 0.75
46 [Progressive-septic granulomatosis: improved prognosis with early diagnosis and targeted therapy. Report of 5 cases]. Monatsschr Kinderheilkd 1985 0.75
47 [Neuroblastoma in 1987 (1)]. Pediatrie 1987 0.75
48 Thanatophoric dysplasia with cloverleaf-skull. Case report and review of the literature. Eur J Pediatr 1982 0.75
49 [Wilms tumor]. Urologe A 2006 0.75
50 Surgical management of Wilms tumor with intracardiac neoplastic extension. Thorac Cardiovasc Surg 1994 0.75
51 [High-dose chemoradiotherapy with bone marrow transplantation as a consolidation treatment of neuroblastoma. Results in 49 unselected patients with stage IV cancer and older than 1 year. Report of the LMCE neuroblastoma group]. Klin Padiatr 1987 0.75
52 Experience treating a patient with Bloom syndrome and acute myelogenous leukemia. Med Pediatr Oncol 1998 0.75
53 Allogeneic and autologous bone marrow transplantation in acute leukemia: the Essen Experience. Haematol Blood Transfus 1990 0.75
54 [Therapy of abdominal neuroblastoma in Essen]. Langenbecks Arch Chir Suppl Kongressbd 1996 0.75
55 Etoposide toxicity on human neuroblastoma cells in vitro is enhanced by preceeding hyperthermia. Med Pediatr Oncol 2001 0.75
56 Microarray-analysis: a new approach to study the molecular mechanisms of thermo-chemotherapy. Klin Padiatr 2003 0.75
57 [Focus on neuroblastoma in 1987. 2: Treatment]. Pediatrie 1987 0.75
58 Effect of specific activity on neuroblastoma uptake of I-123-meta-iodobenzylguanidine in nude mice xenografted with SK-N-SH cells. Oncol Rep 2011 0.75
59 [NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin's lymphoma in children and adolescents. Part 3: An intermediate term analysis of the B-NHL/B-ALL]. Klin Padiatr 1994 0.75
60 Wilms tumor with intracardiac neoplastic extension. Urol Int 1994 0.75